For research use only, not for therapeutic use.
FK962 (CAT: I017361) is a compound known for its cognitive-enhancing actions and potential anti-dementia properties. It acts as an enhancer of somatostatin release, a neuropeptide involved in various physiological functions, including memory and cognition. FK962 is believed to improve cognitive function by modulating somatostatinergic signaling in the brain. While further research is needed to fully understand its mechanism of action and therapeutic potential, FK962 holds promise as a compound that could potentially benefit individuals with cognitive impairments or dementia-related conditions.
| Catalog Number | I017361 |
| CAS Number | 283167-06-6 |
| Molecular Formula | C₁₄H₁₇FN₂O₂ |
| Purity | ≥95% |
| Reference | [1]. Tokita K, et al. FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats. Eur J Pharmacol. 2005 Dec 19;527(1-3):111-20.<br>[2]. McCarthy AD, et al. FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer’s disease. Pharmacol Biochem Behav. 2011 Mar;98(1):76-80. |
